JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spaeth, N.
Right arrow Articles by Buck, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spaeth, N.
Right arrow Articles by Buck, A.
Journal of Nuclear Medicine Vol. 45 No. 11 1931-1938
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Uptake of 18F-Fluorocholine, 18F-Fluoroethyl-L-Tyrosine, and 18F-FDG in Acute Cerebral Radiation Injury in the Rat: Implications for Separation of Radiation Necrosis from Tumor Recurrence

Nicolas Spaeth, DVM1, Matthias T. Wyss, MD1,2, Bruno Weber, PhD1, Stephan Scheidegger, PhD3, Amelie Lutz, MD4, Jorn Verwey, MS5, Ivan Radovanovic, MD6, Jens Pahnke, MD6, Damian Wild, MD1, Gerrit Westera, PhD2, Dominik Weishaupt, MD4, Dirk M. Hermann, MD7, Barbara Kaser-Hotz, DVM3, Adriano Aguzzi, MD6 and Alfred Buck, MD, MS1

1 PET Center, Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
2 Center for Radiopharmaceutical Science of ETH, PSI, and USZ, Paul Scherrer Institute, Villigen, und University Hospital Zurich, Zurich, Switzerland
3 Section of Diagnostic Imaging and Radio-Oncology, Veterinary Hospital, University Zurich, Zurich, Switzerland
4 Institute of Diagnostic Radiology, University Hospital Zurich, Zurich, Switzerland
5 Division of Radiation Medicine, Paul Scherrer Institute, Villigen, Switzerland
6 Institute of Neuropathology, Department of Pathology, University Hospital Zurich, Zurich, Switzerland
7 Department of Neurology, University Hospital Zurich, Zurich, Switzerland

Differentiation between posttherapy radiation necrosis and recurrent tumor in humans with brain tumor is still a difficult diagnostic task. The new PET tracers 18F-fluoro-ethyl-L-tyrosine (FET) and 18F-fluorocholine (N,N-dimethyl-N-18F-fluoromethyl-2-hydroxyethylammonium [FCH]) have shown promise for improving diagnostic accuracy. This study assessed uptake of these tracers in experimental radiation injury. Methods: In a first model, circumscribed lesions were induced in the cortex of 35 rats using proton irradiation of 150 or 250 Gy. After radiation injury developed, uptake of 18F-FET, 18F-FCH, and 18F-FDG was measured using autoradiography and correlated with histology and disruption of the blood-brain barrier as determined with Evans blue. In a second model, uptake of the tracers was assessed in acute cryolesions, which are characterized by the absence of inflammatory cells. Results: Mean 18F-FET, 18F-FCH, and 18F-FDG standardized uptake values in the most active part of the radiation lesion and the contralateral normal cortex (in parentheses) were 2.27 ± 0.46 (1.42 ± 0.23), 2.52 ± 0.42 (0.61 ± 0.12), and 6.21 ± 1.19 (4.35 ± 0.47). The degree of uptake of 18F-FCH and 18F-FDG correlated with the density of macrophages. In cryolesions, 18F-FET uptake was similar to that in radiation lesions, and 18F-FCH uptake was significantly reduced. Conclusion: Comparison of tracer accumulation in cryolesions and radiation injuries demonstrates that 18F-FET uptake is most likely due to a disruption of the blood-brain barrier alone, whereas 18F-FCH is additionally trapped by macrophages. Uptake of both tracers in the radiation injuries is generally lower than the published uptake in tumors, suggesting that 18F-FET and 18F-FCH are promising tracers for separating radiation necrosis from tumor recurrence. However, the comparability of our data with the literature is limited by factors such as different species and acquisition protocols and modalities. Thus, more studies are needed to settle this issue. Nevertheless, 18F-FCH and 18F-FET seem superior to 18F-FDG for this purpose.

Key Words: radiation necrosis • 18F-fluorocholine • 18F-fluoroethyl-L-tyrosine • 18F-FDG • autoradiography


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
C. Plathow and W. A. Weber
Tumor Cell Metabolism Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Stadlbauer, O. Prante, C. Nimsky, E. Salomonowitz, M. Buchfelder, T. Kuwert, R. Linke, and O. Ganslandt
Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging
J. Nucl. Med., May 1, 2008; 49(5): 721 - 729.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. Salber, G. Stoffels, D. Pauleit, A.-M. Oros-Peusquens, N. J. Shah, P. Klauth, K. Hamacher, H. H. Coenen, and K.-J. Langen
Differential Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine, L-3H-Methionine, and 3H-Deoxyglucose in Brain Abscesses
J. Nucl. Med., December 1, 2007; 48(12): 2056 - 2062.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
W. Chen
Clinical Applications of PET in Brain Tumors
J. Nucl. Med., September 1, 2007; 48(9): 1468 - 1481.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. A. Kwee, J. P. Ko, C. S. Jiang, M. R. Watters, and M. N. Coel
Solitary Brain Lesions Enhancing at MR Imaging: Evaluation with Fluorine 18 Fluorocholine PET
Radiology, August 1, 2007; 244(2): 557 - 565.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Rutten, J.-E. Cabay, N. Withofs, C. Lemaire, J. Aerts, V. Baart, and R. Hustinx
PET/CT of Skull Base Meningiomas Using 2-18F-Fluoro-L-Tyrosine: Initial Report
J. Nucl. Med., May 1, 2007; 48(5): 720 - 725.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. T. Wyss, N. Spaeth, G. Biollaz, J. Pahnke, P. Alessi, E. Trachsel, V. Treyer, B. Weber, D. Neri, and A. Buck
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis
J. Nucl. Med., April 1, 2007; 48(4): 608 - 614.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S.-C. Chan, T.-C. Yen, S.-H. Ng, C.-Y. Lin, H.-M. Wang, C.-T. Liao, K.-H. Fan, and J. T.-C. Chang
Differential Roles of 18F-FDG PET in Patients with Locoregional Advanced Nasopharyngeal Carcinoma After Primary Curative Therapy: Response Evaluation and Impact on Management
J. Nucl. Med., September 1, 2006; 47(9): 1447 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Matter, M. T. Wyss, P. Meier, N. Spath, T. von Lukowicz, C. Lohmann, B. Weber, A. R. de Molina, J. C. Lacal, S. M. Ametamey, et al.
18F-Choline Images Murine Atherosclerotic Plaques Ex Vivo
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 584 - 589.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.